Top

Published in:

Open Access 01-04-2016 | Cardiac PET, CT, and MRI (SE Petersen and F Pugliese, Section Editors)

Role of Echocardiography Before Transcatheter Aortic Valve Implantation (TAVI)

Authors: Sveeta Badiani, Sanjeev Bhattacharyya, Guy Lloyd

Published in: Current Cardiology Reports | Issue 4/2016

Abstract

Aortic stenosis (AS) is the most common primary valve disorder in the elderly with an increasing prevalence; transcatheter aortic valve implantation (TAVI) has become an accepted alternative to surgical aortic valve replacement (AVR) in the high risk or inoperable patient. Appropriate selection of patients for TAVI is crucial and requires a multidisciplinary approach including cardiothoracic surgeons, interventional cardiologists, anaesthetists, imaging experts and specialist nurses. Multimodality imaging including echocardiography, CT and MRI plays a pivotal role in the selection and planning process; however, echocardiography remains the primary imaging modality used for patient selection, intra-procedural guidance, post-procedural assessment and long-term follow-up. The contribution that contemporary transthoracic and transoesophageal echocardiography make to the selection and planning of TAVI is described in this article.

Lung B, Baron G, Butchart EG, et al. A prospective study of patients with valvular heart disease in Europe: the Euro Heart Study on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231.CrossRef

Osnabrugge RLJ, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly. Disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–12.CrossRefPubMed

Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111:920–5.CrossRefPubMed

Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N Engl J Med. 1987;317:91–8.CrossRefPubMed

Stephan PJ, Henry AC, Hebeler RF. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol. 1997;79:166–72.CrossRefPubMed

Fedak PWM, Verma S, David TE, et al. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation. 2002;106(8):900–4.CrossRefPubMed

Leon MB, Smith CR, Mack M. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. PARTNER Trial Investigators. N Engl J Med. 2010;363:1597–607.CrossRefPubMed

8.••

Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline on the management of patients with valvular heart disease. J Am Coll Cardiol. 2014;63(22):e57–e185. These guidelines are the most up to date on the management of valvular heart disease. CrossRefPubMed

Asimakopoulos G, Edwards MB, Taylor KM. Aortic valve replacement in patients 80 years of age and older: survival and cause of death based on 1100 cases: collective results from the UK Heart Valve Registry. Circulation. 1997;96:3403–8.CrossRefPubMed

10.

Edwards MB, Taylor KM. Outcomes in nonagenarians after heart valve replacement operation. Ann Thorac Surg. 2003;75:830–4.CrossRefPubMed

11.

Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg. 2004;77:1966–77.CrossRefPubMed

12.

Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714–20.CrossRefPubMed

13.

Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.CrossRefPubMed

14.

Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29:1463–70.CrossRefPubMed

15.

Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.CrossRefPubMed

16.•

Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis. Lancet. 2015;9986:2485–91. This study provides insight into the late clinical outcomes of TAVI compared with standard treatment. CrossRef

17.

Reynolds MR, Magnuson EA, Wang K, et al. Effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis. Results from the PARTNER trial (cohort B) cost. Circulation. 2012;125:1102–09.CrossRefPubMed

18.

PARTNER II trial: https://clinicaltrials.gov/ct2/show/NCT01314313

19.

Jander N, Minners N, Holme I, et al. Outcome of patients with low-gradient “severe” aortic stenosis and preserved ejection fraction. Circulation. 2011;123:887–95.CrossRefPubMed

20.

Holmes DR, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59(13):1200–54.CrossRefPubMed

21.

Poh KK, Levine RA, Solis J, et al. Assessing aortic valve area in aortic stenosis by continuity equation: a novel approach using real time three-dimensional echocardiography. Eur Heart J. 2008;29(20):2526–35.CrossRefPubMedPubMedCentral

22.

Gaspar T, Adawi S, Sachner R, et al. Three-dimensional imaging of the left ventricular outflow tract: impact on aortic valve area estimation by the continuity equation. J Am Soc Echocardiograph. 2012;25:749–57.CrossRef

23.

Cueff C, Serfaty JM, Cimadevill C. Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart. 2011;97:721–6.CrossRefPubMed

24.

Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95.CrossRefPubMed

25.

Clavel MA, Webb JG, Rodes-Cabau J, et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation. 2010;122:1928–36.CrossRefPubMed

26.

Herrmann HC, Pibarot P, Hueter I. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a placement of aortic transcatheter valves (PARTNER) trial analysis. Circulation. 2013;127:2316–26.CrossRefPubMed

27.

Schewel J, Schewel D, Frerker C, et al. TCT 845 clinical outcome of patients with paradoxical low-flow, low-gradient aortic stenosis after transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;60(Suppl B):B245.

28.•

O’Sullivan CJ, Stortecky S, Heg D, et al. Clinical outcomes of patients with low flow low gradient aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantation. Eur Heart J. 2013. doi:10.1093/eurheartj/eht408. This study shows that patients with low flow, low gradient aortic stenosis and paradoxical low flow aortic stenosis have mortality rates compared with patients with normal flow, high gradient aortic stenosis.

29.

Lauten A, Zahn R, Horack M. Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. JACC Cardiovasc Interv. 2012;5:552–9.CrossRefPubMed

30.

Elhmidi Y, Piazza N, Crane M. Clinical presentations and outcomes after transcatheter aortic valve implantation in patients with low flow/low gradient aortic stenosis. Catheter Cardiovasc Interv. 2014;84(2):283–90.CrossRefPubMed

31.

Chiam PT, Chao VT, Tan SY, et al. Percutaneous transcatheter heart valve implantation in a bicuspid aortic valve. JACC Cardiovasc Interv. 2010;3:559–61.CrossRefPubMed

32.

Himbert D, Pontnau F, Messika-Zeitoun D, et al. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. Am J Cardiol. 2012;110:877–83.CrossRefPubMed

33.

Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol. 2010;55(25):2789–800.CrossRefPubMed

34.

Zegdi R, Ciobotaru V, Noghin M, et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol. 2008;51:579–84.CrossRefPubMed

35.

Delgado V, Tops LF, Schuijf JD, et al. Successful deployment of a transcatheter aortic valve in bicuspid aortic stenosis: role of imaging with multislice computed tomography. Circ Cardiovasc Imaging. 2009;2(2):e12–13.CrossRefPubMed

36.

Wijesinghe N, Ye J, Rodés-Cabau J, et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv. 2010;3:1122–5.CrossRefPubMed

37.•

Phan K, Wong S, Phan S, et al. TAVI in patients with bicuspid aortic valve stenosis—systematic review and meta-analysis. Heart, Lung Circ. 2015. doi:10.1016/j.hlc.2014.12.163. This meta-analysis confirms the feasibility of TAVI in patients with bicuspid aortic stenosis.

38.

Bauer T, Linke A, Sievert H, et al. Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from the German TAVI Registry). Am J Cardiol. 2014;113:518–21.CrossRefPubMed

39.

Kochman J, Huczek Z, Scisło P, et al. Comparison of one- and 12-month outcomes of transcatheter aortic valve replacement in patients with severely stenotic bicuspid versus tricuspid aortic valves (results from a Multicenter Registry). Am J Cardiol. 2014;114(5):757–62.CrossRefPubMed

40.

Spatuzza P, Ruparelia N, Latib A. Bicuspid aortic valves and TAVI: is it still an exclusion criterion? State of the art and open issues. Interv Cardio. 2015;7(4):379–85.CrossRef

41.

Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8:162–72.CrossRefPubMed

42.

Enriquez- Sarano M, Atkins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382–94.CrossRefPubMed

43.

Nombela-Franco L, Barbosa Ribeiro H, Urena M, et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement. A comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014;63(24):2643–58.CrossRefPubMed

44.

Sabaté M, Canovas S, García E, et al. In hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: data from the TAVR National Registry 2010-2011. Rev Esp Cardiol. 2013;66:949–58.CrossRefPubMed

45.

Barbanti M, Webb J, Hahn RT, et al. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial cohort A. Circulation. 2013;128:2776–84.CrossRefPubMed

46.

Hutter A, Bleiziffer S, Richter V, et al. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation. Ann Thorac Surg. 2013;95:77–84.CrossRefPubMed

47.

Zahn R, Gerckens U, Linke A, et al. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013;112:272–9.CrossRefPubMed

48.

Bedogni F, Latib A, Brambilla N, et al. Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve revalving system: a multicenter registry. Circulation. 2013;128:2145–53.CrossRefPubMed

49.

Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. Acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55(11):1080–90.CrossRefPubMed

50.

Poliacikova P, Cockburn J, Pareek N, et al. Prognostic impact of pre-existing right ventricular dysfunction on the outcome of transcatheter aortic valve implantation. J Invasive Cardiol. 2013;25(3):142–5.PubMed

51.

Vogt PR, Brunner-LaRocca H, Sidler P, et al. Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality. Eur J Cardiothorac Surg. 2000;17:134–9.CrossRefPubMed

52.

Webb JG, Wood DA, Ye J. Transcatheter valve-in valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848–57.CrossRefPubMed

53.

Kempfert J, Van Linden A, Linke A. Transapical off pump valve-in-valve implantation in patients with degenerated aortic xenografts. Ann Thorac Surg. 2010;89:1934–41.CrossRefPubMed

54.

Eggebrecht H, Schafer U, Treede H, et al. Valve in valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv. 2011;4(11):1218–27.CrossRefPubMed

55.

Dvir D, Webb J, Brecker S, et al. Valvular heart disease. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves. Results from the Global Valve in Valve Registry. Circulation. 2012;126:2335–44.CrossRefPubMed

56.

Azadani AL, Tseng EE. Advances in Interventional Cardiology. Transcatheter heart valves for failing bioprostheses. State of the art review for valve in valve implantation. Circ Cardiovasc Interv. 2011;4:621–8.CrossRefPubMed

57.

Zamorano JL, Badano LP, Bruce C, et al. Document reviewers: EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J. 2011;12:557–84.

58.

Babaliaros V, Junagadhwalla Z, Lerakis S, et al. Use of balloon aortic valvuloplasty to size the aortic annulus before implantation of a balloon expandable transcatheter heart valve. JACC Cardiovasc Interv. 2010;3:114–8.CrossRefPubMed

59.

Rivard AL, Bartel T, Bianco RW, et al. Evaluation of aortic root and valve calcifications by multi-detector computed tomography. J Heart Valve Dis. 2009;18:662–70.PubMed

60.

Delgado V, Kapadia S, Schalij MJ, et al. Transcatheter aortic valve implantation: implications of multimodality imaging in patient selection, procedural guidance, and outcomes. Heart. 2012;98:743–54.CrossRefPubMed

61.

John D, Buellesfeld L, Yuecel S, et al. Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv. 2010;3:233–43.CrossRefPubMed

62.

Haensig M, Lehmkuhl L, Rastan AJ, et al. Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical-aortic valve implantation. Eur J Cardiothorac Surg. 2012;41:1234–40.CrossRefPubMed

63.

Kalavrouziotis D, Rodés-Cabau J, Bagur R, et al. Transcatheter aortic valve implantation in patients with severe aortic stenosis and small aortic annulus. J Am Coll Cardiol. 2011;58:1016–24.CrossRefPubMed

64.

Chin D. Echocardiography for transcatheter aortic valve implantation. Eur J Echocardiogr. 2009;10:i21–9.CrossRefPubMed

65.

Piazza N, De Jaegere P, Schultz C, et al. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. 2008;1:74–81.CrossRefPubMed

66.

Blanke P, Reinohl J, Schlensak C, et al. Prosthesis oversizing in balloon-expandable transcatheter aortic valve implantation is associated with contained rupture of the aortic root. Circ Cardiovasc Interv. 2012;5:540–8.CrossRefPubMed

67.

Kempfert J, Van Linden A, Lehmkuhl L, et al. Aortic annulus sizing: echocardiographic versus computed tomography derived measurements in comparison with direct surgical sizing. Eur J Cardiothorac Surg. 2012;42:627–33.CrossRefPubMed

68.

Saitoh T, Shiota M, Izumo M, et al. Comparison of left ventricular outflow geometry and aortic valve area in patients with aortic stenosis by 2-dimensional versus 3-dimensional echocardiography. Am J Cardiol. 2012;109:1626–31.CrossRefPubMed

69.

Messika-Zeitoun D, Serfaty J-M, Brochet E, et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol. 2010;55:186–94.CrossRefPubMed

70.

Hahn RT, Khalique O, Williams MR, et al. Predicting paravalvular regurgitation following transcatheter valve replacement: utility of a novel method for three-dimensional echocardiographic measurements of the aortic annulus. J Am Soc Echocardiogr. 2013;26:1043–52.CrossRefPubMed

71.

Jilaihawi H, Kashif M, Fontana G, et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol. 2012;59:1275–86.CrossRefPubMed

72.

Smith L, Dworakowski R, Bhan A, et al. Real-time three-dimensional transoesophageal echocardiography adds value to transcatheter aortic valve implantation. J Am Soc Echocardiogr. 2013;26:359–69.CrossRefPubMed

73.

Santos N, de Agustin JA, Almeria C, et al. Prosthesis/annulus discongruence assessed by three-dimensional transoesophageal echocardiography: a predictor of significant paravalvular aortic regurgitation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 2012;13:931–7.CrossRefPubMed

74.

Khalique OK, Kodali SK, Paradis JM, et al. Aortic annular sizing using a novel 3-dimensional echocardiographic method—use and comparison with cardiac computed tomography. Circ Cardiovasc Imaging. 2014;7:155–63.CrossRefPubMed

75.

Husser O, Holzamer A, Resch M, et al. Prosthesis sizing for transcatheter aortic valve implantation—comparison of three dimensional transoesophageal echocardiography with multislice computed tomography. Int J Cardiol. 2013;168(4):3431–8.CrossRefPubMed

76.

Tops LF, Krishnan SC, Schuijf JD, et al. Noncoronary applications of cardiac multidetector row computed tomography. J Am Coll Cardiol Cardiovasc Imaging. 2008;1:94–106.CrossRef

77.

Knight J, Kurtcuoglu V, Muffly K, et al. Ex vivo and in vivo coronary ostial locations in humans. Surg Radiol Anat. 2009;31:597–604.CrossRefPubMed

78.

Litmanovich DE, Ghershin E, Burke DA, et al. Imaging in transcatheter aortic valve replacement (TAVR): role of the radiologist. Insights Imaging. 2014;5(1):123–45.CrossRefPubMedPubMedCentral

79.

Bloomfield GS, Gillam LD, Hahn RT, et al. A practical guide to multimodality imaging of transcatheter aortic valve imaging. J Am Coll Cardiol Img. 2012;5(4):441–55.CrossRef

80.

Jilaihawi H, Bonan R, Asgar A, et al. Anatomic suitability for present and next generation transcatheter aortic valve prostheses: evidence for a complementary multidevice approach to treatment. JACC Cardiovasc Interv. 2010;3:859–66.CrossRefPubMed

81.

Kurra V, Lieber ML, Sola S, et al. Extent of thoracic aortic atheroma burden and long-term mortality after cardiothoracic surgery: a computed tomography study. JACC Cardiovasc Imaging. 2010;3:1020–9.CrossRefPubMed

82.

Ghanem A, Müller A, Nähle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55:1427–32.CrossRefPubMed

Title: Role of Echocardiography Before Transcatheter Aortic Valve Implantation (TAVI)
Authors: Sveeta Badiani
Sanjeev Bhattacharyya
Guy Lloyd
Publication date: 01-04-2016
Publisher: Springer US
Published in: Current Cardiology Reports / Issue 4/2016
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-016-0715-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The STEP trials

Springer Medicine

Role of Echocardiography Before Transcatheter Aortic Valve Implantation (TAVI)

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2016

Clinical Application of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention for Stable Coronary Artery Disease

State of the Art of Combined Heart-Lung Transplantation for Advanced Cardiac and Pulmonary Dysfunction

Percutaneous Coronary Intervention: Relationship Between Procedural Volume and Outcomes

Impact of Right-Sided-Catheter-Based Valve Implantation on Decision-Making in Congenital Heart Disease

Cardiac CT Imaging of Plaque Vulnerability: Hype or Hope?

Coronary Sinus Stent: Could It Help in Refractory Chronic Stable Angina?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page